BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2839147)

  • 1. The iron(III)-adriamycin complex inhibits cytochrome c oxidase before its inactivation.
    Hasinoff BB; Davey JP
    Biochem J; 1988 Mar; 250(3):827-34. PubMed ID: 2839147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adriamycin (doxorubicin)-induced inactivation of cytochrome c oxidase depends on the presence of iron or copper.
    Hasinoff BB; Davey JP; O'Brien PJ
    Xenobiotica; 1989 Feb; 19(2):231-41. PubMed ID: 2543148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin and its iron(III) and copper(II) complexes. Glutathione-induced dissociation; cytochrome c oxidase inactivation and protection; binding to cardiolipin.
    Hasinoff BB; Davey JP
    Biochem Pharmacol; 1988 Oct; 37(19):3663-9. PubMed ID: 2845993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex.
    Hasinoff BB
    Biochem J; 1990 Feb; 265(3):865-70. PubMed ID: 2306220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of the cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yL)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin.
    Hasinoff BB
    Agents Actions; 1989 Mar; 26(3-4):378-85. PubMed ID: 2544086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The iron(III) and copper(II) complexes of adriamycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).
    Hasinoff BB
    Agents Actions; 1990 Mar; 29(3-4):374-81. PubMed ID: 2160191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV.
    Nicolay K; de Kruijff B
    Biochim Biophys Acta; 1987 Jul; 892(3):320-30. PubMed ID: 3036220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation of rat erythrocyte membrane induced by adriamycin-Fe3+.
    Miura T; Muraoka S; Ogiso T
    Pharmacol Toxicol; 1991 Oct; 69(4):296-300. PubMed ID: 1659698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin.
    Demant EJ
    Biochem Pharmacol; 1991 Feb; 41(4):543-52. PubMed ID: 1847635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADH oxidation in submitochondrial particles protects respiratory chain activity against damage by adriamycin-Fe3+.
    Demant EJ
    Eur J Biochem; 1983 Dec; 137(1-2):113-8. PubMed ID: 6317378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin.
    Vile GF; Winterbourn CC
    Cancer Res; 1990 Apr; 50(8):2307-10. PubMed ID: 2156615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxyradical production results from the Fe3(+)-doxorubicin complex undergoing self-reduction by its alpha-ketol group.
    Hasinoff BB
    Biochem Cell Biol; 1990 Dec; 68(12):1331-6. PubMed ID: 1964792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reduction of the iron(III)-doxorubicin complex.
    Hasinoff BB
    Free Radic Biol Med; 1989; 7(6):583-93. PubMed ID: 2559881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of inhibition of purified and mitochondrial cytochrome c oxidase by psychosine (beta-galactosylsphingosine).
    Cooper CE; Markus M; Seetulsingh SP; Wrigglesworth JM
    Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):139-44. PubMed ID: 8382474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of thioridazine with cardiac cytochrome oxidase; enzyme activity and drug binding studies.
    Moubarak AS; Muhoberac BB
    Biochem Biophys Res Commun; 1991 Sep; 179(2):1063-9. PubMed ID: 1654898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of cytochrome oxidase by diaminomaleonitrile.
    Alexander K; Baskin SI
    Biochim Biophys Acta; 1987 Mar; 912(1):41-7. PubMed ID: 3030429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of peroxidized cardiolipin to inactivation of bovine heart cytochrome c oxidase.
    Musatov A
    Free Radic Biol Med; 2006 Jul; 41(2):238-46. PubMed ID: 16814104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescein mercuric acetate specifically displaces zinc from cytochrome oxidase.
    Moubarak A; Pan LP; Millett F
    Biochem Biophys Res Commun; 1987 Mar; 143(3):1030-6. PubMed ID: 3032179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formamide probes a role for water in the catalytic cycle of cytochrome c oxidase.
    Liu Y; Hill BC
    Biochim Biophys Acta; 2007 Jan; 1767(1):45-55. PubMed ID: 17184725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies as probes of cytochrome oxidase structure and function.
    Nicholls P; Cooper CE; Leece B; Freedman JA; Chan SH
    Prog Clin Biol Res; 1988; 274():637-51. PubMed ID: 2841682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.